- Home
- RMBI vs TNXP Comparison
RMBI vs TNXP Comparison
Compare RMBI & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBI
- TNXP
- Stock Information
- Founded
- RMBI 1887
- TNXP 2007
- Country
- RMBI United States
- TNXP United States
- Employees
- RMBI N/A
- TNXP N/A
- Industry
- RMBI Major Banks
- TNXP Biotechnology: Pharmaceutical Preparations
- Sector
- RMBI Finance
- TNXP Health Care
- Exchange
- RMBI Nasdaq
- TNXP Nasdaq
- Market Cap
- RMBI 125.7M
- TNXP 111.1M
- IPO Year
- RMBI 2019
- TNXP N/A
- Fundamental
- Price
- RMBI $13.84
- TNXP $17.02
- Analyst Decision
- RMBI
- TNXP Strong Buy
- Analyst Count
- RMBI 0
- TNXP 2
- Target Price
- RMBI N/A
- TNXP $585.00
- AVG Volume (30 Days)
- RMBI 29.4K
- TNXP 957.1K
- Earning Date
- RMBI 04-28-2025
- TNXP 05-12-2025
- Dividend Yield
- RMBI 4.33%
- TNXP N/A
- EPS Growth
- RMBI 1.10
- TNXP N/A
- EPS
- RMBI 0.92
- TNXP N/A
- Revenue
- RMBI $42,915,048.00
- TNXP $10,094,000.00
- Revenue This Year
- RMBI N/A
- TNXP $12.17
- Revenue Next Year
- RMBI N/A
- TNXP $789.15
- P/E Ratio
- RMBI $14.93
- TNXP N/A
- Revenue Growth
- RMBI 2.81
- TNXP 29.94
- 52 Week Low
- RMBI $10.15
- TNXP $6.76
- 52 Week High
- RMBI $15.15
- TNXP $672.00
- Technical
- Relative Strength Index (RSI)
- RMBI 68.11
- TNXP 49.09
- Support Level
- RMBI $11.98
- TNXP $14.33
- Resistance Level
- RMBI $12.80
- TNXP $22.25
- Average True Range (ATR)
- RMBI 0.56
- TNXP 1.98
- MACD
- RMBI 0.19
- TNXP -0.36
- Stochastic Oscillator
- RMBI 88.70
- TNXP 34.95
About RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.